Literature DB >> 11163109

Methylation of the p16(Ink4a) tumor suppressor gene 5'-CpG island in breast cancer.

N H Nielsen1, G Roos, S O Emdin, G Landberg.   

Abstract

Methylation of the p16(Ink4a) tumor suppressor gene 5'CpG island was analyzed in 104 primary breast cancer specimens using Southern blotting and methylation specific polymerase chain reaction (PCR) (MSP). Eight and four tumors, respectively, showed methylation, and all MSP positive tumors were detected by Southern blotting. To investigate possible methylation not detectable by these methods, bisulphite genomic sequencing was performed in 220 clones from 14 selected tumors. Absent methylation or methylation of single CpG dinucleotides prevailed in all tumors, but of the MSP positive tumors, three contained alleles with methylation of 31 or 32 of the 32 analyzed CpG dinucleotides in the island. Partially methylated alleles were also observed. In a group with low p16(Ink4a) expression determined by Western blotting, four randomly selected tumors contained several identical clones with methylation of 15 CpG dinucleotides by bisulphite genomic sequencing but with a methylation pattern that did not support detection by either Southern blotting or MSP, increasing the potential significance of p16(Ink4a) methylation in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11163109     DOI: 10.1016/s0304-3835(00)00674-1

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  16 in total

Review 1.  The evidence for functional non-CpG methylation in mammalian cells.

Authors:  Vibha Patil; Robyn L Ward; Luke B Hesson
Journal:  Epigenetics       Date:  2014-04-09       Impact factor: 4.528

2.  A genetic variant in CDKN2A/B gene is associated with the increased risk of breast cancer.

Authors:  Soodabeh ShahidSales; Mehraneh Mehramiz; Faezeh Ghasemi; Amir Aledavood; Mehri Shamsi; Seyed Mahdi Hassanian; Majid Ghayour-Mobarhan; Amir Avan
Journal:  J Clin Lab Anal       Date:  2017-03-09       Impact factor: 2.352

3.  Aberrant promoter methylation of p16 in colorectal adenocarcinoma in North Indian patients.

Authors:  Pooja Malhotra; Rakesh Kochhar; Kim Vaiphei; Jai Dev Wig; Safrun Mahmood
Journal:  World J Gastrointest Oncol       Date:  2010-07-15

4.  p16 gene methylation in colorectal cancers associated with Duke's staging.

Authors:  J Yi; Z W Wang; H Cang; Y Y Chen; R Zhao; B M Yu; X M Tang
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

5.  A common variant of CDKN2A (p16) predisposes to breast cancer.

Authors:  T Debniak; B Górski; T Huzarski; T Byrski; C Cybulski; A Mackiewicz; S Gozdecka-Grodecka; J Gronwald; E Kowalska; O Haus; E Grzybowska; M Stawicka; M Swiec; K Urbański; S Niepsuj; B Waśko; S Góźdź; P Wandzel; C Szczylik; D Surdyka; A Rozmiarek; O Zambrano; M Posmyk; S A Narod; J Lubinski
Journal:  J Med Genet       Date:  2005-05-06       Impact factor: 6.318

6.  Promoter Hypermethylation in Tumor Suppressing Genes p16 and FHIT and Their Relationship with Estrogen Receptor and Progesterone Receptor Status in Breast Cancer Patients from Northern India.

Authors:  Mohammad Raish; Varinderpal S Dhillon; Arif Ahmad; Mushtaq Ahmad Ansari; Shahid Mudassar; Mohammad Shahid; Vineeta Batra; Pawan Gupta; Bhudev Chandra Das; Nk Shukla; Syed Akhtar Husain
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

7.  Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients.

Authors:  Sondes Karray-Chouayekh; Fatma Trifa; Abdelmajid Khabir; Nouredine Boujelbane; Tahia Sellami-Boudawara; Jamel Daoud; Mounir Frikha; Rachid Jlidi; Ali Gargouri; Raja Mokdad-Gargouri
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-06       Impact factor: 4.553

8.  Methylation status of p16 INK4A tumor suppressor gene in Iranian patients with sporadic breast cancer.

Authors:  Sadeq Vallian; Mandana Sedaghat; Isar Nassiri; Ali Frazmand
Journal:  J Cancer Res Clin Oncol       Date:  2009-01-06       Impact factor: 4.553

9.  CpG island tumor suppressor promoter methylation in non-BRCA-associated early mammary carcinogenesis.

Authors:  Shauna N Vasilatos; Gloria Broadwater; William T Barry; Joseph C Baker; Siya Lem; Eric C Dietze; Gregory R Bean; Andrew D Bryson; Patrick G Pilie; Vanessa Goldenberg; David Skaar; Carolyn Paisie; Alejandro Torres-Hernandez; Tracey L Grant; Lee G Wilke; Catherine Ibarra-Drendall; Julie H Ostrander; Nicholas C D'Amato; Carola Zalles; Randy Jirtle; Valerie M Weaver; Victoria L Seewaldt
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-03       Impact factor: 4.254

10.  Some molecular and clinical aspects of genetic predisposition to malignant melanoma and tumours of various site of origin.

Authors:  Tadeusz Debniak
Journal:  Hered Cancer Clin Pract       Date:  2007-06-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.